CDK4 is found to be amplified in colorectal cancer cells compared to normal cells [50,51], and evidence has shown that inhibiting certain CDKs such as CDK1, 2, 4/6, and 9 is useful in enhancing colorectal cancer cell (HCT-116) death [52]. Here, CDK4 is linked to colorectal cancer.